Skip to main content
. 2020 Feb;9(1):43–50. doi: 10.21037/tp.2019.12.03

Figure 1.

Figure 1

Overview of genetic landscape in sequenced pediatric patients with Ras aberrancies. Prevalence of RAS and Ras-pathway aberrations in hematologic malignancies broken down by gender, age, disease type, disease status at sequencing and clinical outcome with concurrent mutational burden.